Skip to content

Clinical trials

Recruiting Carcinoma, Ovarian Epithelial trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Recruiting Country / region: Italy Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20222
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Azienda USL Reggio Emilia - IRCCS1
Blue Earth Diagnostics1
Daiichi Sankyo1
Ente Ospedaliero Ospedali Galliera1
European Institute of Oncology1
Guardant Health, Inc.1
Jvan Casarin, MD PhD1
Light Chain Bioscience - Novimmune SA1
TORL Biotherapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial12
Fallopian Tube Neoplasms4
Ovarian Neoplasms3
Anemia, Refractory, with Excess of Blasts1
COVID-191
Carcinoma, Lobular1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.